观点网讯:8月31日,甫康生物科技(上海)股份有限公司向香港交易所提交上市申请书,农银国际、民银资本、复星国际资本担任联席保荐人。免责声明:本文内容与数据由观点根据公开信息整理,不构成投资建议,使用前请核实。
Source Link观点网讯:8月31日,甫康生物科技(上海)股份有限公司向香港交易所提交上市申请书,农银国际、民银资本、复星国际资本担任联席保荐人。免责声明:本文内容与数据由观点根据公开信息整理,不构成投资建议,使用前请核实。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.